Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced resolution process for IRS drug intermediates via diastereomeric salt crystallization. Enhances purity and reduces manufacturing costs for pharmaceutical supply chains.
Patent CN105392891B enables high-yield production of optically active D/L amino acids with thiol groups. Enhances supply chain reliability and reduces manufacturing costs for peptide synthesis.
Patent CN100432060C details advanced synthesis of levofloxacin intermediates. Enhance supply chain reliability and reduce manufacturing costs with optimized chiral resolution.
Patent CN101928229A reveals a cost-effective route for L-2-aminobutanamide hydrochloride, offering high purity and scalable manufacturing for global API supply chains.
Novel enzymatic resolution process ensures greater than 99 percent ee value. Cost-effective Raney nickel catalyst reduces manufacturing expenses for reliable supply chain partners.
Patent CN1156474C details novel chiral isoquinoline synthesis offering improved solubility and bioavailability for cardiovascular drug manufacturing.
Patent CN102887885B details high-purity esomeprazole sodium synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN1403456A details a novel resolution and quaternization process for chiral tetrahydroberberine, offering cost reduction in cardiovascular drug manufacturing and enhanced supply chain reliability.
Patent CN1317481A details a scalable synthetic route for 4,5-diamino shikimic acid derivatives from isophthalic acid, offering significant cost reduction and supply stability for neuraminidase inhibitor manufacturing.
Patent CN117106845A reveals enzymatic resolution for chiral pyridine diols. This method offers mild conditions and high atom economy for pharmaceutical intermediate manufacturing supply chains.
Discover the asymmetric transformation method for L-2-aminobutanamide hydrochloride. Enhance purity and reduce costs in levetiracetam manufacturing with our advanced synthesis route.
Patent CN1146554C details a scalable route for Formula I and XIV intermediates. Eliminates chromatography, improves yield via dynamic resolution. Ideal for API manufacturing cost reduction.
Novel diastereoselective alkylation route for high-purity anti-atherosclerotic intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN109734653A details novel resolution for Argatroban intermediates ensuring high purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN101130503B details a robust synthesis route for L-Serine-15N. Achieves high 15N abundance and purity for reliable supply chain integration.
Patent CN110256261B details a novel copper-coordinated chiral resolution method for high-purity L-2-amino-1-butanol, offering significant supply chain and cost advantages.
Advanced synthesis of HIV integrase inhibitor intermediates via patent CN114394983A. Offers scalable routes and high-purity enzymatic resolution for global pharmaceutical supply chains.
Patent CN1184109A reveals a novel diastereoselective synthesis for high-purity cycloalkanol indole carboxylic acids, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN114214375A details a novel enzymatic route for high-purity Ruxolitinib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104163821A enables high-yield diazabicyclo compound production. Reduces costs and ensures supply continuity for pharmaceutical manufacturers globally.